Thomas Jefferson University

Jefferson Digital Commons
Division of Cardiology Faculty Papers

Division of Cardiology

1-2011

Dyssynchrony in obese subjects without a history of cardiac
disease using velocity vector imaging
Bhaskar Purushottam MD
Jefferson Medical College

Anoop C. Parameswaran MD, MPH
Jefferson Medical College

Vincent M. Figueredo MD
Jefferson Medical College

Follow this and additional works at: https://jdc.jefferson.edu/cardiologyfp
Part of the Cardiology Commons

Let us know how access to this document benefits you
Recommended Citation
Purushottam MD, Bhaskar; Parameswaran MD, MPH, Anoop C.; and Figueredo MD, Vincent M.,
"Dyssynchrony in obese subjects without a history of cardiac disease using velocity vector
imaging" (2011). Division of Cardiology Faculty Papers. Paper 9.
https://jdc.jefferson.edu/cardiologyfp/9
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been
accepted for inclusion in Division of Cardiology Faculty Papers by an authorized administrator of the Jefferson
Digital Commons. For more information, please contact: JeffersonDigitalCommons@jefferson.edu.

1

As submitted to:
Journal of the American Society of Echocardiography
And later published as:
Dyssynchrony in Obese Subjects without a History of Cardiac Disease Using
Velocity Vector Imaging
Volume 24, Issue 1, January 2011, Pages 98-106
DOI: 10.1016/j.echo.2010.10.003

Bhaskar Purushottam MDa, Anoop C. Parameswaran MD, MPHa, Vincent M. Figueredo MDa

(a) Einstein Institute for Heart and Vascular Health, Albert Einstein Medical Center and Jefferson Medical
College, Philadelphia.

Running Title: Intra Left Ventricular Dyssynchrony in Obesity

Conflict of Interest: The authors have no conflicts of interest to report.

Key Words: Dyssynchrony, Obese, Velocity Vector Imaging

Corresponding Author:

Vincent M. Figueredo, MD, FACC, FASE
Associate Professor of Medicine, Jefferson Medical College
Director, Cardiovascular Diseases Fellowship Programs
Albert Einstein Medical Center
5501 Old York Road, Levy 3, Philadelphia, PA 19141
215-456-8819
figueredov@einstein.edu

2

Abstract

Aim: To examine the occurrence of intra-left ventricular (LV) dyssynchrony in obese versus non-obese
subjects without known cardiac disease using velocity vector imaging (VVI).

Methods: One hundred ninety consecutive subjects with no known cardiac disease had their
echocardiograms analyzed using VVI after excluding subjects with QRS duration >120ms or LV ejection
fraction (LVEF) <55%. Study subjects were divided into two groups based on body mass index (BMI):
obese (BMI >30 kg/m2) and non-obese (BMI <30 kg/m2).

Results: The final cohort included 136 subjects (74 were obese), 32% female and mean age 55 + 16 years.
Occurrence of intra LV dyssynchrony was higher in the obese compared to non-obese group.

Conclusions: There was an increased prevalence of intra LV dyssynchrony in obese subjects, especially
longitudinal and radial dyssynchrony. This dyssynchrony may signal a mechanism by which obesity
predisposes to the development of heart failure.
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Obesity is a modern epidemic, with greater than 60 million adults affected in the United States alone.1
Obesity is an important risk factor for heart failure in both men and women. Increased body mass index
(BMI) has been reported in 11% and 14% of heart failure cases in men and women, respectively2. Left
ventricular hypertrophy and dilatation1, 3-5, which are known precursors of heart failure6, 7 are associated with
obesity. Also, obesity is associated with altered LV remodeling, possibly due to increased hemodynamic
load, neurohormonal activation and increased cytokine production8. Myocardial triglyceride content appears
to increase progressively with body mass index9. Recent experimental investigations suggest cardiac
steatosis (excessive accumulation of cytosolic triglycerides in the myocardial cells), increased myocardial
fibrosis, lipoapoptosis, and the activation of certain cardiac genes may underlie obesity cardiomyopathy10, 11.
Recent studies using positron emission tomography found that in obese young women, insulin resistance and
obesity are related to alterations in fatty acid metabolism, which could play a role in decreased cardiac
performance11-15. Whatever these intricate and complex molecular mechanisms may be, evidence suggests
that long standing obesity results in LV structural and functional alterations producing volume overload,
eccentric LV hypertrophy, systolic and diastolic dysfunction and heart failure16.

Marfella and associates demonstrated a higher occurrence of interventricular dyssynchrony in obese subjects
using 2-dimensional (2-D) echocardiography with Doppler17. To our knowledge there have been no studies
thus far examining the incidence of intra LV dyssynchrony in obese subjects who do not have a history of
significant cardiac disease.

Myocardial contraction and relaxation are complex processes involving longitudinal, circumferential, radial
and tortional forces. Velocity vector imaging (VVI) is a novel technique that uses myocardial speckle
tracking to assess myocardial mechanics from 2-D echocardiography18. VVI uses an algorithm that
automatically tracks motion of the tissue/cavity border and motion of reference points (mitral annulus),
displaying tissue motion, direction and velocity (Figure 1). Unlike tissue Doppler imaging (TDI), VVI
measures velocities independent of transducer angle. Also, in a recent study, Lim et al., demonstrated that
the accuracy of TDI in assessing LV wall regional motion is limited in dilated ventricles and probably
affects LV dyssynchrony measurement19.

Our aim was to examine the prevalence of intra LV dyssynchrony in obese subjects who have no history of
cardiac disease and compare them with non-obese controls using VVI.
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Methods:

Five hundred consecutive subjects who had their 2-D echocardiograms performed at Albert Einstein Medical
Center, Philadelphia between November 2008 and March 2009 on an Acuson Sequoia C512 (Sequoia,
Siemens Medical Solutons Inc., Mountain View, California20) were screened. 310 subjects were excluded
with the following exclusion criteria: 1) history of coronary artery disease; 2) left ventricular ejection
fraction (LVEF) < 55%; 3) diastolic dysfunction greater than grade 1 (mitral early to late diastolic inflow
peak velocity ratio > 0.8, deceleration time of the mitral inflow < 200ms, isovolumetric relaxation time <
60ms, pulmonary venous systolic to diastolic peak velocity ratio < 1 and mitral early inflow to early diastolic
annular septal tissue peak velocity ratio > 9 as listed in American Society of Echocardiography criteria21) ; 4)
QRS duration > 120ms; 5) moderate or severe valvular heart disease (using Doppler echocardiographic
parameters-central jet > 4cm2 or jet area > 20% of left atrial area for mitral regurgitation, central jet width >
25% or vena contracta > 0.3cm2 or pressure half time < 500ms for aortic regurgitation, central jet area > 5cm
or proximal isovelocity surface radius > 0.5cm for tricuspid regurgitation, jet size by color Doppler > 10mm
for pulmonary regurgitation-for regurgitant lesions22; mean gradient > 20 mm of Hg or aortic valve area of <
1.5cm2 or aortic jet velocity of > 3m/s for aortic stenosis, mitral valve area < 1.5cm2 or mean gradient of >
5mm of Hg for mitral stenosis, tricuspid valve area < 1cm2 or mean gradient > 5mm of Hg or inflow timevelocity time integral > 60cm or pressure half time > 190ms for tricuspid stenosis, peak velocity > 3m/s or
peak gradient > 36mm of Hg for pulmonic stenosis-for stenotic lesions23) ; 6) pacemaker; 7) hypertrophic
cardiomyopathy; 8) pericardial effusion or disease; 9) poor quality images where the myocardium was not
visible and; 10) any subject admitted to the intensive care unit. Subjects were divided into two groups based
on body mass index (BMI): 1) BMI of greater than or equal to 30 kg/m2 (obese) and 2) BMI less than 30
kg/m2 (non-obese). We also compared morbidly obese subjects (BMI of greater than or equal to 40kg/m2) to
obese subjects (BMI ≥ 30 to <40).

VVI was performed using the Acuson Sequoia C512. Images were captured using frame rates used for
traditional 2-D echocardiograms (30-60 frames/sec.). VVI uses a series of tracking algorithms whose details
are described elsewhere18. In brief, the endocardial-myocardial interface is traced manually in a single frame
on a digital cine-loop. When the image is processed, a complex algorithm tracks each pixel and the
myocardial velocity vectors are displayed in cine format. The lengths of the vectors are proportional to the
magnitude of velocity and the direction of the arrows corresponds to the direction of myocardial motion.
One cardiac cycle was analyzed if the RR intervals were regular, and an average of 3 beats was used if RR
intervals were irregular. Apical four chamber, two chamber and short axis views at the papillary muscle level
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were studied off-line. In the apical four and two chamber views, a trace was made (along the endocardialmyocardial interface) from the septal to lateral mitral annulus and from the inferior to anterior mitral annulus
respectively. In the short axis view at the level of papillary muscles, a circumferential trace was made
starting at 12 o’clock position and ending at the same point in a clockwise direction, excluding the papillary
muscles. Approximately one point per myocardial segment was used to draw the trace. A point of reference
was placed at the apex in the two and four chamber views to calculate longitudinal velocities and strain. The
point of reference was moved to the left ventricular cavity to calculate radial velocities. In the short axis
view, the point of reference was at the center of the left ventricle to calculate circumferential velocities and
strain. Longitudinal velocity, longitudinal strain and radial velocities were measured at the basal septal, basal
lateral, basal anterior and basal inferior walls in the apical four and two chamber views. The circumferential
velocities and strain were measured in the short axis view at the papillary muscle level. Time to peak
velocities and strain were calculated from the onset of the QRS complex to the peak systolic velocity or peak
strain respectively during the ejection phase. We defined mechanical dyssynchrony as longitudinal opposing
wall delay >75 ms by VVI based on a prior study24. As there are no published criteria for circumferential
dyssynchrony and since we were looking at the maximum delay between all 6 segments in the short axis
view, not just the opposing wall delays, we used a higher number (maximum delay ≥ 100 ms) to define
circumferential dyssynchrony. We used a value of 75 ms for septal to lateral wall radial delay. An example
of longitudinal and circumferential LV dyssynchrony analysis using the above mentioned VVI technique is
illustrated in figures 2 and 3, respectively.

Patient demographics, clinical characteristics, hemodynamic measurements, laboratory data,
echocardiographic parameters and electrocardiographic data were collected (Tables 1 and 2). Patient
demographics collected were age, gender and race. Clinical characteristics collected were any history of
hypertension (blood pressure > 140/90mm of Hg as defined by the 7th report of the ‘Joint National
Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure’25 or if they are on
anti-hypertensives), diabetes mellitus (fasting plasma glucose > 126mg/dl as per the ‘American Diabetes
Association’26 or if they are on anti-diabetes treatment), prior history of transient ischemic attack27, ischemic
stroke28 or intracranial hemorrhage, hypercholesterolemia (low density lipoprotein levels > 130mg/dl as per
‘National Cholesterol Education Program’ report29 or if they are on a HMG CoA reductase inhibitor), a
diagnosis of obstructive sleep apnea30 , a diagnosis of stable chronic obstructive pulmonary disease31 and
whether the subjects were on hemodialysis. Hemodynamic measurements recorded were heart rate and
systolic and diastolic blood pressure recorded immediately prior to performing the echocardiogram.
Laboratory data obtained were hemoglobin and creatinine, which were done closest to the time of the
echocardiogram. QRS duration was recorded from the electrocardiogram. All echocardiographic
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measurements were based on ASE guidelines. Left ventricular diastolic dimension (LVIDd), septal wall
thickness (SWT), posterior wall thickness (PWT), left atrial diameter and LV mass were measured using 2Dguided M-mode, assuming that the LV is a prolate ellipse in the parasternal long-axis acoustic window32. LV
mass was indexed to body surface area. Diastolic dysfunction and the grade of dysfunction21, LVEF (was
calculated using the modified Simpson’s rule32) and pulmonary artery systolic pressures33 were measured.

The study was approved by the institutional research board of Albert Einstein Medical Center, Philadelphia.
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Statistical Analysis:

Data were analyzed using the SPSS 10 (Chicago, IL, USA). Continuous data are presented as mean ± SD.
Means were compared using a two-tailed student t test. Multivariate analysis was performed using the
regression model. Chi-square test was used to compare categorical variables. A p value less than 0.05 were
considered significant. Co-efficient of variation (COV) was used to measure the inter and intra-observer
variability on 20 random obese and non-obese subjects.
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Results:
The final cohort consisted of 136 subjects. Thirty subjects were excluded from the obese group and 24 from
the non-obese group. Among the 30 excluded obese subjects, 17 were excluded due to incomplete data and
13 due to poor quality echocardiograms. Among the 24 excluded non-obese subjects, 15 were excluded due
to incomplete data and 9 due to poor quality echocardiograms. In the final cohort, 74 were obese subjects
and 62 were non-obese controls. Mean age was 55 ± 16 years, 32% were female, mean QRS duration was 84
± 9 ms and mean LVEF was 60 ± 8%. Of note, no subject had a LVEF < 55%, while others were more
hyperdynamic. Demographic and clinical data were well matched between the two groups (Table 1).
Echocardiographic, hemodynamic and electrocardiographic parameters are reported in Table 2. Among the
72 obese subjects, 50 (68%) had a BMI between 30 to 40 and 24 (32%) had a BMI ≥ 40 (morbidly obese).
The inter and intra-observer variability was calculated for all the different VVI measurements done in the
study for the 20 random obese and non-obese subjects. The COV for longitudinal, radial and circumferential
time to peak velocities were 5%, 6% and 6%, respectively for inter-observer variability; 5%, 5% and 6%,
respectively for intra-observer variability. The COV for longitudinal and circumferential strain were 8% and
8%, respectively for inter-observer variability; 7% and 8%, respectively for intra-observer variability.

Velocity Vector Analysis (Table 3)
a) Longitudinal velocity
Among the obese subjects, 9.4% (n=7) had a longitudinal septal to lateral (S-L) wall time to peak delay of
>75ms whereas, 0% of the non-obese subjects had evidence of dyssynchrony (p=0.01). There were no
significant differences in the longitudinal absolute peak velocities of the basal myocardial walls (measured in
the apical 2 chamber and 4 chamber views) between the two groups (obese and non-obese).
b) Radial velocity
Among the obese subjects, 31.0 % (n=23) had a radial septal to lateral (S-L) wall time to peak delay of
>75ms as compared to 8.0% (n=5) among non-obese subjects (p< 0.01). There were no significant
differences in the radial absolute peak velocities of the basal myocardial walls (measured in the apical 2
chamber and 4 chamber views) between the two groups.
c) Circumferential velocity
Among the obese subjects, 27.0% (n=20) had a maximum opposing wall time to peak circumferential delay
of > 100ms compared to 1.6% (n=1) among non-obese subjects (p< 0.01). There were no significant
differences in the circumferential absolute peak velocities between the obese and non-obese subjects.

Strain Analysis
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a) Longitudinal Strain
Among the obese subjects, 58.1% (n=43) had a maximum opposing wall time to peak delay in longitudinal
strain of > 100ms compared to 33.8% (n=21) among non-obese subjects (p<0.01). There were no significant
differences in the longitudinal strain between the two groups.
b) Circumferential Strain
Among the obese subjects, 10.8% (n=8) had a maximum opposing wall time to peak delay in circumferential
strain of > 100ms as compared to 1.6% (n=1) among non-obese subjects (p=0.03). There were no significant
differences in circumferential peak strain between the obese and non-obese subjects.

Comparison Between Obese and Non-Obese Groups
There was significantly increased time to peak delay in longitudinal, radial and circumferential velocities
and delay in time to peak longitudinal and circumferential strain in obese subjects when compared to nonobese subjects (Table 4). Obese subjects had a higher LVIDd, LV mass, QRS duration, systolic and diastolic
blood pressures (but all still within normal reference limits), when compared to the non-obese subjects. Even
after adjusting for these confounding variables, in addition to age, race, gender, LV mass index and LVEF,
the obese subjects had a significantly increased LV dyssynchrony when compared to the non-obese subjects
on a multivariate analysis (Table 5).

Comparison of Dyssynchrony between Obese and Morbidly Obese groups (Table 6)
There were no significant differences in longitudinal, radial and circumferential time to peak velocities and
time to peak longitudinal and circumferential strain or myocardial peak velocities and peak strain between
obese and morbidly obese subjects.

Comparison of LVEF between obese subjects with and without dyssynchrony (Figure 4)
Obese subjects with time to peak delay in longitudinal septal to lateral wall velocity of >75ms had a lower
LVEF (55 ± 0%) when compared to obese subjects with time to peak longitudinal S-L wall delay of <75ms
(60 ± 7%; p<0.01). Obese subjects with time to peak delay in radial S-L wall velocity >75ms, delay in time
to peak circumferential velocity >100ms or delay in time to peak longitudinal and circumferential strain had
similar LVEF when compared to non-obese subjects.

Comparison of LVEF between obese and non-obese subjects with dyssynchrony
The LVEF was lower in the obese group when compared to the non-obese group among the subjects with a
longitudinal strain maximum opposing wall delay >100ms (59 + 6% vs. 62ms + 8%; p>0.05), radial septallateral wall delay >75ms (59 + 7% vs. 63 + 9%; p>0.05) and radial maximum opposing wall delay >100ms
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(60 + 7% vs. 61 + 9%; p>0.05). There were very few non-obese subjects with longitudinal, circumferential
and circumferential strain dyssynchrony (table 3.) to make a statistically appropriate comparison.

Subjects with QRS duration >100ms
Seven study subjects had QRS duration >100ms; six were obese. When comparing dyssynchrony between
subjects with QRS duration >100ms and those with QRS duration <100ms, only longitudinal strain septallateral wall delay was increased (86.43 + 39.97ms vs. 48.56 + 72.14ms; p<0.05).
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Discussion:

Multiple parameters of intra LV dyssynchrony, including radial and longitudinal dyssynchrony, were more
frequent in obese subjects when compared to non-obese subjects. After multivariate analysis, obesity
remained a significant independent predictor of intra LV dyssynchrony. Interestingly, there were no
significant differences in the peak myocardial velocities or peak myocardial strain between obese and nonobese subjects.

Obesity is associated with left ventricular hypertrophy and dilatation1, 3-5; known precursors of heart failure6,
7

. Obesity is associated with altered LV remodeling, possibly due to increased hemodynamic load,

neurohormonal activation and increased cytokine production8. There is very little data examining ventricular
dyssynchrony in obese subjects. One study by Marfella et al., in 2004 described interventricular
dyssynchrony among premenopausal obese women, which improved significantly after a 10% weight loss17.
They used pulmonary vein flow analysis, E/A ratios (ratio of mitral early and late diastolic flow velocities)
and myocardial performance index (MPI= [isovolumetric relaxation time + isovolumetric contraction
time]/left ventricular ejection time) to assess interventricular dyssynchrony. Tumuklu et al., suggested that
decreased regional strain rate seen in obese, compared to the non-obese subjects, was a reflection of
subclinical changes in LV systolic function34. However, they did not study dyssynchrony between these two
groups.

Ten Harkel et al., investigated intra LV dyssynchrony and LV volumes in 73 healthy adolescents (age range
of 12 – 18 years) using real-time three-dimensional echocardiography35. In contrast to the present study, they
found dyssynchrony values were independent of weight, length and body surface area. However, there were
significant differences in these study populations. In the present study, subjects were older than the
adolescents (55 versus 15 years old). Further, Ten Harkel et al., did not report the proportion of adolescents
who were overweight or obese, therefore making it difficult to assess the association of obesity and intra LV
dyssynchrony. On similar lines, Ng and et al., prospectively investigated the impact of age, gender and other
physiological parameters on LV longitudinal and radial synchrony using TDI and 2-dimensional speckle
tracking and found that dyssynchrony was independent of BMI36. The mean BMI of the study group was
25.8 + 4.9, and the proportion of obese subjects was not reported. Therefore, it is difficult to arrive at any
conclusions with regards to obesity and LV dyssynchrony based on these prior studies.

Bernheim et al., found that patients with normal, clinically indicated exercise echocardiograms (LVEF
>50%) and QRS duration <120ms, who had abnormal dyssynchrony parameters at rest had a higher resting
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heart rate and achieved a lower workload37. They felt that this indicated early myocardial impairment. Chang
et al., found that LV systolic and diastolic dyssynchrony in asymptomatic patients with hypertension who
had a QRS duration <120ms and normal range LVEF were significantly associated with LV filling
pressure38. In view of the above studies and with the results of our study, intra LV dyssynchrony may play a
role in the mechanisms underlying heart failure development in obese subjects.

Myocardial triglyceride content appears to increase progressively with body mass index9. Experimental
investigations suggest that this cardiac steatosis (excessive accumulation of cytosolic triglycerides in the
myocardial cells), increases myocardial fibrosis and lipoapotosis and may underlie obesity
cardiomyopathy10, 11. Rijzewijk et al., demonstrated that myocardial steatosis is an independent predictor of
diastolic dysfunction in patients with type 2 diabetes mellitus39 and Kankaanpää et al., showed that the free
fatty acid levels were significantly correlated with LV mass40. These studies applied magnetic resonance
imaging and spectroscopy techniques to quantify myocardial triglyceride content. However, quantification of
regional differences of triglyceride content in the myocardium is difficult as the heart is perpetually in
motion and is surrounded by a large depot of adipocytes (epicardial fat pad) that interferes with
measurements41. Thus, whether regional variations in myocardial steatosis exist and plays a role in the
observed dyssynchrony in obese patients requires further study. Of note, the obese subjects in the present
study had an increased LV mass, LVIDd, PWT, blood pressure, and QRS duration when compared to the
non-obese subjects. However, these confounding variables did not influence our results after multivariate
analysis (Table 4).

As mentioned earlier, we found no differences in the peak velocities and strain achieved by the different
myocardial walls between obese and non-obese subjects. Contrary to our study, Tumuklu et al., using
reconstructed spectral pulsed wave tissue Doppler showed significantly decreased myocardial peak
velocities, regional and global strain among obese subjects when compared to non-obese controls34. The
present study was cross-sectional so that we could not test the possibility of dyssynchrony preceding changes
in peak velocities and strain. Further, dyssynchrony looks at the difference in the time taken to achieve peak
velocities or strain between opposing walls and not at the absolute velocities or strain and changes in these
different parameters need not simultaneously occur.

Contrary to the existing literature, there were fewer obese subjects in our study with obstructive sleep apnea
and elevated pulmonary artery pressures. This could be explained by the fact that our study was retrospective
and many of our subjects had not yet had a sleep study. Thus the reported number of subjects with
obstructive sleep apnea is observational in this population. It is likely that the number of obese subjects with

13

obstructive sleep apnea is underestimated. Given the fact that we excluded subjects who had moderate or
severe tricuspid regurgitation, low LVEF, diastolic dysfunction greater than grade 1 or those who were
admitted to the intensive care unit, several obese subjects with elevated pulmonary artery pressures were
excluded.

Our study raises multiple questions and possibilities regarding the occurrence of dyssynchrony in obese
subjects and its role in the causation of systolic dysfunction in obese subjects. With obesity being a rising
worldwide epidemic, and with its harmful effects on cardiac function, and contribution to heart failure,
further studies are warranted. It would also be interesting to see if obese individuals are better cardiac resynchronization therapy responders than their non-obese counterparts, as we see an increased occurrence of
dyssynchrony among obese subjects.
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Limitations:

This is a retrospective study limited to an inner city single medical center. Since a lower frame rate was used
for VVI, it is conceivable that some very rapid velocities may not be recorded. Nevertheless, comparison
between the time to peak velocities between two walls should remain valid. Some MRI studies looking at
the heterogeneity in LV contraction used frame rates ranging from 14 – 35 ms. This is comparable with the
30-60 f/s (16 – 33 ms) used in this study. Unlike speckle tracking echocardiography, which can measure
radial strain in the short axis views42, VVI cannot measure these radial velocities in the short axis view and
LV torsion that could have given us more information about LV function. Waist to hip ratio was not
calculated as these were not standard measurements for subjects who underwent echocardiography. Waist to
hip ratio is a stronger correlate of LV dysfunction and mortality when compared to BMI43. As this was a
retrospective study, we could not accurately estimate the duration of obesity for each subject and therefore
assess its effect on dyssynchrony. As this was not a longitudinal study and clinical effects were not
measured, these findings should be viewed as thought provoking with future studies assessing the potential
contribution of intra LV dyssynchrony in obese subjects with clinical endpoints such as heart failure.
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Conclusions:

There was increased intra LV dyssynchrony among obese subjects when compared to non-obese subjects,
especially longitudinal and radial dyssynchrony. This dyssynchrony may signal one mechanism by which
obesity predisposes to the development of heart failure.
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Figure legends:

Figure 1. Myocardial velocity vector imaging. The figure shows the VVI with myocardial velocity vectors.
The direction of the arrows represents the direction of contraction and the length of the arrow is proportional
to myocardial velocity. Top right: Myocardial velocity curves. Bottom right: M-mode representation of
dyssynchrony with the red phase representing systole and the blue phase representing diastole.

Figure 2. An example of longitudinal LV dyssynchrony analysis using the velocity vector imaging (VVI)
technique. The figure shows a longitudinal VVI analysis. Top left: Myocardial longitudinal velocity vectors
are shown. Bottom left: Longitudinal velocity curves for basal septal and basal lateral myocardial walls are
shown. Top right: The time to peak longitudinal velocities of the basal septal (base left) and basal lateral
(base right) walls are measured in this view. In this analysis, the longitudinal septal to lateral wall delay is
34ms.

Figure 3. An example of circumferential LV dyssynchrony analysis using the VVI technique. The figure
shows the circumferential VVI analysis of an obese subject. Top left: Myocardial circumferential velocity
vectors are shown. Bottom left: Circumferential velocity curves for the various myocardial segments seen in
the short axis view at the level of the papillary muscles. Top right: The time to peak circumferential
velocities of the anterior, anterolateral, infero-lateral, inferior, inferoseptal and antero-septal walls (starting
from 12 ‘O’ clock position and proceeding in a clockwise direction) are shown. In this VVI analysis, the
max. circumferential wall dyssynchrony is 167ms.

Figure 4. A bar diagram comparing the mean LVEF and SD of the obese subjects with and without
longitudinal septal to lateral (S-L) wall delay of >75ms.
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Table 1. Baseline demographic, clinical and laboratory data.

Variable

Obese (n=74)

Non-Obese (n=62) p value

Age (in years)

53 + 13

57 + 18

0.13

Male

22 (29%)

22 (35%)

0.58

African-Americans

64 (86%)

40 (65%)

<0.01

Hypertension

57 (77%)

39 (63%)

0.09

Diabetes Mellitus

26 (35%)

17 (27%)

0.36

Hypercholesterolemia

20 (27%)

14 (23%)

0.69

History of TIA or Stroke

3 (4%)

3 (5%)

0.54

Smoker

18 (24%)

19 (31%)

0.44

COPD

2 (3%)

4 (6%)

0.41

Known OSA*

1 (1%)

3 (5%)

0.62

On Hemodialysis

2 (3%)

4 (6%)

0.41

Hemoglobin (g/dL)

11.9 + 2.5

12. + 1.7

0.56

Creatinine (mg/dL)

1.4 + 1.4

1.8 + 2.7

0.26

TIA=transient ischemic attack; OSA=obstructive sleep apnea;
COPD=chronic obstructive pulmonary disease
*Not all the study subjects had a sleep study to confirm OSA
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Table 2. Baseline hemodynamic, echocardiographic and electrocardiographic data
Variables

Obese (n=74)

Non-Obese (n=62)

p value

Heart Rate (beats per minute)

79 + 15

81 + 17

0.66

Systolic Blood Pressure (mm of Hg)

141 + 22

129 + 19

<0.01

Diastolic Blood Pressure (mm of Hg)

79 + 12

73 + 10

<0.01

Ejection fraction (%)

60 + 7

61 + 8

0.22

Pulmonary Artery Systolic Pressure (mm of Hg)

33 + 11

31 + 13

0.55

Diastolic Dysfunction* (Grade 1)

51 (69%)

33 (53%)

0.08

Left Atrial Diameter (cm)

3.5 + 0.6

3.4 + 0.6

0.48

Left Ventricular Diastolic Dimension (cm)

4.8 + 0.5

4.5 + 0.5

<0.01

Septal Wall Thickness (cm)

1.1 + 0.1

1 + 0.2

0.01

Posterior Wall Thickness (cm)

1.1 + 0.2

1 + 0.2

<0.01

Left Ventricular Mass (gms)

193 + 57

155 + 56

<0.01

Left Ventricular Mass Index (LVMI) (gms/m2)

91 + 23

89 + 30

0.72

QRS Duration (ms)

85 + 10

81 + 8

<0.01

T-Wave Inversions

13 (18%)

16 (26%)

0.29

Left Ventricular Hypertrophy**

8 (11%)

5 (8%)

0.77

Q waves

1 (1%)

3 (5%)

0.32

Hemodynamic Parameters

Echocardiographic Parameters

Electrocardiographic Parameters

*None of the subjects had diastolic dysfunction greater than grade 1.
**Based on Sokolow-Lyon or Cornell criteria. mm=millimeters; Hg=Mercury; cm=centimeters;
ms=milliseconds; gms=grams
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Table 3. Occurrence of dyssynchrony among obese and non-obese subjects

Dyssynchrony Parameters

Obese (n=74) Non-Obese (n=62) p value

Longitudinal Dyssynchrony
Septal to lateral (S-L) wall delay >75ms

7 (9.4%)

0

0.01

Anterior to inferior (A-I) wall delay >75ms

6 (8.1%)

2 (3.2%)

0.20

Maximum delay >100ms

31 (41.8%)

5 (8%)

<0.01

S-L wall delay >75ms

23 (31%)

5 (8%)

<0.01

A-I wall delay >75ms

20 (27%)

10 (16.1%)

0.14

Maximum delay >100ms

43 (58.1%)

21 (33.8%)

<0.01

S-L wall delay >75ms

58 (78.3%)

24 (38.7%)

<0.01

A-I wall delay >75ms

60 (81%)

12 (19.3%)

<0.01

Maximum delay >100ms

67 (90.5%)

39 (62.9%)

<0.01

12 (16.2%)

1 (1.6%)

<0.01

Anterolateral to Inferoseptal (AL-IS) wall delay >100ms 9 (12.1%)

1 (1.6%)

0.02

Inferolateral to Anteroseptal (IL-AS) wall delay >100ms 12 (16.2%)

0

<0.01

Maximum Delay >100ms

20(27%)

1 (1.6%)

<0.01

A-I wall delay >100ms

3 (4%)

0

0.25

AL-IS wall delay >100ms

8 (10.8%)

1 (1.6%)

0.03

IL-AS wall delay >100ms

3 (4%)

0

0.25

Maximum Delay >100ms

8 (10.8%)

1 (1.6%)

0.03

Longitudinal Strain Dyssynchrony

Radial Dyssynchrony

Circumferential Dyssynchrony
Anterior to inferior wall (A-I) delay >100ms

Circumferential Strain Dyssynchrony

ms=milliseconds
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Table 4. Comparison of dyssynchrony parameters between the obese and non-obese subjects using univariate
analysis

Dyssynchrony Parameters

Obese (n=74) Non-Obese (n=62) p value

Longitudinal Dyssynchrony (ms)
Septal to lateral (S-L) wall delay

31 + 53

10 + 15

<0.01

Anterior to inferior (A-I) wall delay

22 + 37

13 + 22

0.07

Maximum delay

109 + 83

55 + 32

<0.01

S-L wall delay

69 + 88

29 + 33

<0.01

A-I wall delay

55 + 62

34 + 41

0.01

Maximum delay

134 + 84

86 + 54

<0.01

S-L wall delay

165 + 95

72 + 66

<0.01

A-I wall delay

153 + 96

50 + 50

<0.01

Maximum delay

255 + 105

133 + 78

<0.01

55 + 71

18 + 27

<0.01

Anterolateral to Inferoseptal (AL-IS) wall delay 59 + 70

28 + 26

<0.01

Inferolateral to Anteroseptal (IL-AS) wall delay 61 + 78

23 + 23

<0.01

Maximum Delay

97 + 95

39 + 27

<0.01

A-I wall delay

22 + 42

16 + 22

0.24

AL-IS wall delay

30 + 48

20 + 31

0.16

IL-AS wall delay

17 + 31

16 + 23

0.91

Maximum Delay

44 + 53

29 + 32

0.04

Longitudinal Strain Dyssynchrony (ms)

Radial Dyssynchrony (ms)

Circumferential Dyssynchrony (ms)
Anterior to inferior wall (A-I) delay

Circumferential Strain Dyssynchrony (ms)

All data is presented as Mean + SD; ms=milliseconds
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Table 5. Comparison of dyssynchrony parameters between obese and non-obese using multivariate* analysis

Dyssynchrony Parameters

Obese (n=74)

Non-Obese (n=62)

p value

Longitudinal S-LWall Delay (ms)

31 + 53

10 + 15

<0.01

Radial S-L Wall Delay (ms)

165 + 95

72 + 66

<0.01

Circumferential Max. Opposing Wall Delay (ms)

97 + 95

39 + 27

0.01

Longitudinal Strain S-L Wall Delay (ms)

69 + 88

29 + 33

<0.01

Circumferential Strain Max. Opposing Wall Delay (ms)

44 + 53

29 + 32

0.88

*adjusted for age, gender, race, LVEF, diastolic dysfunction, SWT, PWT, LVIDd, QRS duration, LV mass,
LV mass index, systolic and diastolic blood pressure. S-L=Septal to Lateral; ms=millisecond
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Table 6. Comparison of dyssynchrony parameters between morbidly obese and obese subjects using
univariate analysis

Dyssynchrony Parameters

Morbidly Obese (n=24) Obese (n=50) p value

Longitudinal Dyssynchrony (ms)
Septal to lateral (S-L) wall delay

40 + 65

26 + 47

0.35

Anterior to inferior (A-I) wall delay

23 + 35

22 + 38

0.89

Maximum delay

125 + 98

101 + 74

0.29

S-L wall delay

70 + 73

68 + 95

0.92

A-I wall delay

69 + 60

48 + 62

0.18

Maximum delay

145 + 74

129 + 89

0.41

S-L wall delay

157 + 92

169 + 97

0.60

A-I wall delay

195 + 96

134 + 91

0.01

Maximum delay

279 + 113

244 + 100

0.19

51 + 59

57 + 76

0.69

Anterolateral to Inferoseptal (AL-IS) wall delay 82 + 81

48 + 62

0.07

Inferolateral to Anteroseptal (IL-AS) wall delay 54 + 63

64 + 84

0.55

Maximum Delay

94 + 87

99 + 100

0.84

A-I wall delay

36 + 63

16 + 25

0.14

AL-IS wall delay

20 + 26

34 + 55

0.14

IL-AS wall delay

17 + 29

17 + 32

0.97

Maximum Delay

43 + 43

45 + 58

0.86

Longitudinal Strain Dyssynchrony (ms)

Radial Dyssynchrony (ms)

Circumferential Dyssynchrony (ms)
Anterior to inferior wall (A-I) delay

Circumferential Strain Dyssynchrony (ms)

All data presented as Mean + SD; ms=milliseconds
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Figure 1
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Figure 2

